glp-1 gip dual agonist GIPR/GLP-1R therapies for diabetes and weight loss—chemistry, physiology, and clinical applications The dual agonist action of

Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm2018 executive summary

Sleep: The Free Longevity Drug A nationwide analysis in SLEEP Advances found that insufficient sleep ranked just behind smoking as a predictor of shortened life expectancy across over 3,000 US counties (McAuliffe et al., 2025)

The goal is to give the reader who is genuinely trying to make a good decision every piece of verified information available, and to be transparent about what couldn't be confirmed

1 Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications that were first approved in 2005 for type 2 diabetes (T2D)

2010 Jun 28;13(3):98100

For weight management (Zepbound), coverage is less common, though it is expanding